Takeda is Cutting up to 200 Jobs in Vienna and Putting its New Seestadt Lab on Hold
Summary
Takeda is cutting up to 200 jobs in Vienna as part of a broader global restructuring led by its new CEO Julie Kim. The company is also putting its newly completed Seestadt Aspern life sciences lab on hold and is looking for a subtenant. Takeda says it will keep its plasma-based research, production, and broader value chain in Austria, and it still plans further investment in remaining facilities. The move creates uncertainty for researchers and for Vienna’s push to position itself as an innovation hub.
Classifications
industries
No industries detected
applications
No applications detected
AskAI Classifications
Labels
No AI classifications detected